NTLA-2001: Clinical Trials

1 trial of NTLA-2001, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow NTLA-2001: new trials by email Literature Review of NTLA-2001 trials Research Report on NTLA-2001

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-2001 in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN) and Patients With Transthyretin Amyloidosis-Related Cardiomyopathy (ATTR-CM)
NTLA-2001 - Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy
Phase 1CompletedIntellia Therapeutics722020-11-052026-01-30

Conditions studied

Amyloid Neuropathies, Familial (1)  ·  Amyloidosis (1)  ·  Cardiomyopathies (1)  ·  Polyneuropathies (1)

Sponsors

Intellia Therapeutics (1)

Countries

France (1)  ·  New Zealand (1)  ·  Sweden (1)  ·  United Kingdom (1)

Results publications

PMID 34175043, PMID 34215024, PMID 39555828, PMID 41002250